Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2005
10/13/2005US20050229263 Transgenesis by sperm-mediated gene transfer
10/13/2005US20050229262 Peptide production
10/13/2005US20050229261 Method for producing biologically active human factor VIII in the milk of transgenic animals driven by mammary-specific expression cassettes
10/13/2005US20050229260 Compound screens relating to insulin deficiency or insulin resistance
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228169 Polypeptide binding to human syntaxin 1a
10/13/2005US20050227940 Amplifying interfering RNA (RNAi) expression and effects
10/13/2005US20050227939 Modulation of kallikrein 6 expression
10/13/2005US20050227938 Antisense modulation of TFAP2C expression
10/13/2005US20050227937 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
10/13/2005US20050227934 Diabetes; DNA or RNA molecules comprising at least ten contiguous bases having a sequence in a pancreatic islet microRNA
10/13/2005US20050227931 Use of macrolides in pest control
10/13/2005US20050227924 Peyer's patch and/or M-cell targeting ligands
10/13/2005US20050227357 Recombinant Penicillium funiculosum for homologous and heterologous protein production
10/13/2005US20050227356 Novel compositions and methods for genetic manipulation of Rhodococcus bacteria
10/13/2005US20050227353 Methods of inducing differentiation of stem cells
10/13/2005US20050227344 Mixture obtained from penicillium funiculosu
10/13/2005US20050227340 Recombinant escherichia coli and overproduction method of polyhydroxybutyrate using the strain
10/13/2005US20050227337 Method for producing ascorbic acid intermediates
10/13/2005US20050227336 Methods for producing optically active alcohols
10/13/2005US20050227334 Method for producing L-glutamic acid by fermentation accompanied by precipitation
10/13/2005US20050227331 Conjoined polynucleotide catalysts
10/13/2005US20050227330 growth hormone supergene family; prolongs circulating half-lives of protein therapeutics in the body so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via the added cysteine
10/13/2005US20050227329 Recombinant fibroblast growth factor analogs
10/13/2005US20050227328 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/13/2005US20050227326 Obtaining vector comprising a modified PLAC4 having a mutation in one or more Pribnow box-like sequences into which gene encoding target protein has been inserted; reduction in gene expression when vector is cloned in bacteria; transformation
10/13/2005US20050227325 Recombinant polynucleotide
10/13/2005US20050227324 Comprise a single antigen binding arm and an Fc region; exhibits enhanced stability in vivo compared to a Fab antibody fragment
10/13/2005US20050227322 Recombinant prion-like genes and proteins and materials and methods comprising the same
10/13/2005US20050227321 Producing antimicrobial peptides (AMPs) by using microbes; not necessary to offset the positive charges of multiple copies of AMPs in multimeric constructs; enables the use of a wider range of multimers and carrier peptides
10/13/2005US20050227320 For cleaving and sequencing polysaccharides such as glycosaminoglycans, removing polysaccharides from solution, inhibiting anticoagulant activity, inhibiting angiogenesis, treating cancer, inhibiting maternal malarial infection
10/13/2005US20050227319 DNA sequences coding for enzymes capable of facilitating the synthesis of linear alpha-1,4 glucans in plants, fungi and microorganisms
10/13/2005US20050227318 Site-specific incorporation of redox active amino acids into proteins
10/13/2005US20050227317 Mammalian expression system
10/13/2005US20050227316 Using restriction enzyme digestion and ligase sealing to generate vector comprising preferential gene sequences; directed protein evolution
10/13/2005US20050227315 Exogenous protein expression system in an avian system
10/13/2005US20050227313 Polypeptide cleavage process
10/13/2005US20050227311 Novel carotenoid ketolases
10/13/2005US20050227303 Method and composition for diagnosis of melanocytic lesions
10/13/2005US20050227291 cyclic peptide consisting of three genetically encodable amino acid residues,at least one of said amino acid residues is a serine, threonine, or cysteine; employed in a variety of research and medical applications, including methods of treating a patient for hepatitis C infection.
10/13/2005US20050227289 Antibodies to erythropoietin receptor and uses thereof
10/13/2005US20050227287 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPSc
10/13/2005US20050227286 Method of preparing a standard diagnostic gene transcript pattern
10/13/2005US20050227285 Control of gene expression in eukaryotic cells
10/13/2005US20050227282 Human extracellular matrix-1
10/13/2005US20050227281 Using immobilized oligonucleotides as tools in synthesis, selection, amplification and evolution of non-natural molecules based on nucleic acid templates
10/13/2005US20050227280 Proteases
10/13/2005US20050227277 Apoptosis proteins
10/13/2005US20050227273 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
10/13/2005US20050227272 Isolated nucleic acid with polynucleotide encoding a polypeptide that interacts with I kappa B alpha probe; diagnosis or pre-diagnosis of Type 1 diabetes in an individual
10/13/2005US20050227271 Microarray having microarray identification information stored in the form of a spot, method of producing the microarray and method of using the microarray
10/13/2005US20050227270 Alternatively spliced isoforms of sodium channel, voltage gated, type XI, alpha (SCN11A)
10/13/2005US20050227268 Expression cloning using a tagged cDNA library
10/13/2005US20050227263 Method of performing PCR amplification on a microarray
10/13/2005US20050227262 polynucleotides that code for polypeptide comprising beta-ketoacyl synthase, acetyl transferase, dehydratase, methyltransferase, ketoreductase, and acyl carrier proteins; anticholesterol agents produced by Monascus
10/13/2005US20050227256 Sequence-specific inhibition of small RNA function
10/13/2005US20050227253 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
10/13/2005US20050227251 Method of purifying RNA binding protein-RNA complexes
10/13/2005US20050227250 Human Elk, a voltage-gated potassium channel subunit
10/13/2005US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications
10/13/2005US20050227248 Polypeptides having beta-1,4-GalNAc transferase activity
10/13/2005US20050227247 Contacting a target nucleic acid sequence with PCR reagents of primers and a polymerase enzyme, and an oligonucleotide probe; hybridizing to a target polynucleotide sequence; a fluorescer molecule attached to a first end of the oligonucleotide and a quencher molecule
10/13/2005US20050227246 System for producing Synthetic Promoters
10/13/2005US20050227245 Reagents and methods for identifying and modulating expression of genes regulated by retinoids
10/13/2005US20050227238 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
10/13/2005US20050227237 Human neuronal attachment factor-1
10/13/2005US20050227234 Method for the simultaneous detection of hybridization and vaccination reactions and diagnostic uses thereof
10/13/2005US20050227233 Method for diagnosing and treating schizophrenia
10/13/2005US20050227229 Multiple controls for molecular genetic analyses
10/13/2005US20050227226 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
10/13/2005US20050227225 Stabilization of biomolecules in samples
10/13/2005US20050227224 Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
10/13/2005US20050226895 vaccine to protect salmon against infection by Piscirickettsia salmonis, a gramnegative bacteria; salmonid rickettsial septicaemia
10/13/2005US20050226892 Methods and compositions comprising bacteriophage nanoparticles
10/13/2005US20050226889 Inhibition of viral infection and spread with viral and RhoA-derived peptides
10/13/2005US20050226888 Methods for generating immunity to antigen
10/13/2005US20050226887 Mucin antigen vaccine
10/13/2005US20050226885 Cytolysis of target cells by superantigen conjugates inducing T-cell activation
10/13/2005US20050226866 Bone morphogenic protein specific immunoglobulin for treatment of bone diseases; immunotherapy
10/13/2005US20050226859 Peg-Modified Uricase
10/13/2005US20050226853 Skin substitutes and uses thereof
10/13/2005US20050226851 Lysin-deficient bacteriophages having reduced immunogenicity
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
10/13/2005US20050226848 Transcriptional regulation of gene expression by small double-stranded modulatory RNA
10/13/2005US20050226847 Adeno-associated virus producer system
10/13/2005US20050226846 Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression
10/13/2005DE60104282T2 Lösliche mutante ctla4 moleküle und deren verwendung Soluble CTLA4 mutant molecules and their use
10/13/2005DE102004013843A1 Expression von Nitrilhydratasen im Zwei-Vektor-Expressionssystem Expression of nitrile hydratase in the two-vector expression system
10/13/2005DE102004013335A1 Impfstoff gegen Influenza basierend auf Geflügelpestviren Influenza vaccine based on avian influenza
10/13/2005DE102004011687A1 VGLUT-spezifische dsRNA-Verbindungen VGLUT-specific dsRNA compounds
10/13/2005CA2603585A1 Assay for identifying compounds which affect stability of mrna
10/13/2005CA2565175A1 Cancer diagnosis and treatment using anti-robo1 antibody
10/13/2005CA2563015A1 Transgenic fish with increased unsaturated fatty acid content
10/13/2005CA2562953A1 Humanized and chimeric anti-osm antibodies
10/13/2005CA2562721A1 Detection instrument with the use of polynucleotides mapped on barley chromosome
10/13/2005CA2561978A1 Therapeutic molecules for modulating stability of vegf transcripts
10/13/2005CA2561702A1 Methods for altering protein production rates
10/13/2005CA2561534A1 Ion channel
10/13/2005CA2561450A1 Plants having improved growth characteristics and method for making the same
10/13/2005CA2561376A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
1 ... 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 ... 4023